People · Operator

Jerry M. Anchin

Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology

1
Companies
2
Filings
$3.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vicor Technologies, Inc.BiotechnologySeed$3.7M$120.6M2009
Operator network

Jerry M. Anchin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Frederick M. Hudson · 2 companies · 1 sharedFrederick M. Huds…James E. Skinner · 2 companies · 1 sharedJames E. SkinnerDaniel H. Weiss · 1 companies · 1 sharedDaniel H. WeissDaniel N. Weiss · 1 companies · 1 sharedDaniel N. WeissDavid H. Fater · 1 companies · 1 sharedDavid H. FaterEdward H. Wiesmeier · 1 companies · 1 sharedEdward H. Wiesmei…Edward M. Wiesmeier · 1 companies · 1 sharedEdward M. Wiesmei…Edward Wiesmeier · 1 companies · 1 sharedEdward WiesmeierJames H. Skinner · 1 companies · 1 sharedJames H. SkinnerJerry H. Anchin · 1 companies · 1 sharedJerry H. AnchinJoseph A. Franchetti · 1 companies · 1 sharedJoseph A. Franche…Lloyd C. Chesney · 1 companies · 1 sharedLloyd C. ChesneyThomas J. Bohannon · 1 companies · 1 sharedThomas J. BohannonVicor Technologies, Inc. · $3.7M raisedVicor Technologies, I…Jerry M. AnchinJA
Jerry M. Anchin Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jerry M. Anchin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Frederick M. Hudson12
James E. Skinner12
Joseph A. Franchetti11
Daniel N. Weiss11
David H. Fater11
Thomas J. Bohannon11
Edward M. Wiesmeier11
Lloyd C. Chesney11
Edward H. Wiesmeier11
Daniel H. Weiss11
Jerry H. Anchin11
James H. Skinner11
Edward Wiesmeier11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.